Preliminary Testing of New Treatment for Chronic Leg Wounds
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate the efficacy, dosing, and safety of an
intra-ulcer injection H5.020CMV.PDGF-b in adults who have a venous leg ulcer. The primary
endpoint of this Phase I trial is the determination of the Maximum Tolerated Dose (MTD) for
the intra-ulcer injection of H5.020CMV.PDGF-b.